ROG - Roche Holding AG
SIX
->
Healthcare
->
Drug Manufacturers—General
Basel,
Switzerland
Type: Equity
ROG price evolution
ROG
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $131.7 | $126.45 | $141.45 | $193.72 |
| Short term investments | ||||
| Net receivables | $161.9 | $185.75 | $186.7 | $174.62 |
| Inventory | $153.5 | $157.07 | $169.68 | $177.09 |
| Total current assets | $526.9 | $554.8 | $582.78 | $611.88 |
| Long term investments | $11.1 | $10.35 | $12.76 | $12.84 |
| Property, plant & equipment | $385.2 | $341.7 | $346.33 | $361.53 |
| Goodwill & intangible assets | $483.7 | $476.71 | $489.19 | $488.1 |
| Total noncurrent assets | $990.3 | $966.07 | $985.6 | $999.65 |
| Total investments | $11.1 | $10.35 | $12.76 | $12.84 |
| Total assets | $1517.2 | $1520.87 | $1568.38 | $1611.53 |
| Current liabilities | ||||
| Accounts payable | $50.3 | $46.85 | $51.23 | $52.16 |
| Deferred revenue | ||||
| Short long term debt | $3.5 | $0.34 | $0.35 | $0.38 |
| Total current liabilities | $116.4 | $116.14 | $118.58 | $127.48 |
| Long term debt | $45.4 | $81.15 | $131.25 | $191.32 |
| Total noncurrent liabilities | $141.8 | $194.12 | $244.18 | $305.79 |
| Total debt | $48.9 | $81.49 | $131.61 | $191.7 |
| Total liabilities | $258.2 | $310.25 | $362.76 | $433.27 |
| Shareholders' equity | ||||
| Retained earnings | $1155 | $1131.85 | $1112.81 | $1094.95 |
| Other shareholder equity | -$66.4 | -$88.84 | -$71.03 | -$75.51 |
| Total shareholder equity | $1259 | $1210.61 | $1205.62 | $1178.26 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $131.7 | $235.85 | $232.3 | $191.78 |
| Short term investments | ||||
| Net receivables | $161.9 | $220.15 | $163.09 | $134.42 |
| Inventory | $153.5 | $182.4 | $133.38 | $102.36 |
| Total current assets | $526.9 | $659.87 | $584.07 | $474.18 |
| Long term investments | $11.1 | $14.08 | $16.33 | $15.25 |
| Property, plant & equipment | $385.2 | $371.43 | $326.97 | $272.38 |
| Goodwill & intangible assets | $483.7 | $486.09 | $546.54 | $388.2 |
| Total noncurrent assets | $990.3 | $986.35 | $1014.5 | $789.83 |
| Total investments | $11.1 | $14.08 | $16.33 | $15.25 |
| Total assets | $1517.2 | $1646.21 | $1598.57 | $1264.01 |
| Current liabilities | ||||
| Accounts payable | $50.3 | $57.34 | $64.66 | $35.99 |
| Deferred revenue | ||||
| Short long term debt | $3.5 | $0.5 | ||
| Total current liabilities | $116.4 | $142.54 | $163.95 | $111.51 |
| Long term debt | $45.4 | $216.29 | $190 | $25 |
| Total noncurrent liabilities | $141.8 | $331.21 | $315.72 | $131.74 |
| Total debt | $48.9 | $216.79 | $190 | $25 |
| Total liabilities | $258.2 | $473.75 | $479.67 | $243.25 |
| Shareholders' equity | ||||
| Retained earnings | $1155 | $1098.45 | $981.83 | $873.69 |
| Other shareholder equity | -$66.4 | -$85.26 | -$45.24 | -$19.57 |
| Total shareholder equity | $1259 | $1172.47 | $1118.89 | $1020.75 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $204.58 | $229.15 | $230.82 | $243.85 |
| Cost of revenue | $137.16 | $148.79 | $151.2 | $164.15 |
| Gross Profit | $67.42 | $80.36 | $79.62 | $79.7 |
| Operating activities | ||||
| Research & development | $10.19 | $7.83 | $8.1 | $9.59 |
| Selling, general & administrative | $51.75 | $44.34 | $46.13 | $60.09 |
| Total operating expenses | $36.89 | $53.24 | $51.72 | $79.95 |
| Operating income | $30.54 | $27.12 | $27.89 | -$0.25 |
| Income from continuing operations | ||||
| EBIT | $30.07 | $28.52 | $27.98 | -$0.17 |
| Income tax expense | $5.39 | $7.16 | $7.28 | -$0.13 |
| Interest expense | $1.47 | $2.33 | $2.84 | $3.46 |
| Net income | ||||
| Net income | $23.21 | $19.04 | $17.86 | -$3.5 |
| Income (for common shares) | $23.21 | $19.04 | $17.86 | -$3.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $908.4 | $971.17 | $932.89 | $802.58 |
| Cost of revenue | $601.3 | $650.16 | $583.75 | $510.76 |
| Gross Profit | $307.1 | $321.01 | $349.14 | $291.82 |
| Operating activities | ||||
| Research & development | $35.7 | $35.21 | $29.9 | $29.32 |
| Selling, general & administrative | $202.3 | $218.83 | $193.15 | $182.28 |
| Total operating expenses | $221.8 | $176.58 | $232.49 | $224.54 |
| Operating income | $85.3 | $144.43 | $116.65 | $67.28 |
| Income from continuing operations | ||||
| EBIT | $86.4 | $149.93 | $128.82 | $75.67 |
| Income tax expense | $19.7 | $23.75 | $18.15 | $18.54 |
| Interest expense | $10.1 | $9.55 | $2.54 | $7.13 |
| Net income | ||||
| Net income | $56.6 | $116.63 | $108.13 | $49.99 |
| Income (for common shares) | $56.6 | $116.63 | $108.13 | $49.99 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $23.21 | $19.04 | $17.86 | -$3.5 |
| Operating activities | ||||
| Depreciation | $11.28 | $11.45 | $13.72 | $14.65 |
| Business acquisitions & disposals | $0.01 | $0.7 | $0.99 | |
| Stock-based compensation | $3.43 | $3.8 | $5.02 | $2.05 |
| Total cash flows from operations | $71.88 | $41.98 | $15.71 | $1.83 |
| Investing activities | ||||
| Capital expenditures | -$17.61 | -$6.46 | -$10.92 | -$16.41 |
| Investments | ||||
| Total cash flows from investing | -$17.55 | -$5.76 | -$9.17 | -$15.42 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$50.07 | -$50.09 | -$60.12 | -$25.12 |
| Total cash flows from financing | -$50.69 | -$50.12 | -$60.12 | -$29.37 |
| Effect of exchange rate | $1.56 | -$1.1 | $1.31 | $0.83 |
| Change in cash and equivalents | $5.2 | -$15 | -$52.27 | -$42.13 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $56.6 | $116.63 | $108.13 | $49.99 |
| Operating activities | ||||
| Depreciation | $51.1 | $45.88 | $43.28 | $71.42 |
| Business acquisitions & disposals | $1.7 | -$3.58 | -$168.2 | |
| Stock-based compensation | $14.3 | $11.8 | $16.99 | $13.53 |
| Total cash flows from operations | $131.4 | $129.46 | $124.36 | $165.06 |
| Investing activities | ||||
| Capital expenditures | -$51.4 | -$116.79 | -$70.41 | -$40.38 |
| Investments | ||||
| Total cash flows from investing | -$47.9 | -$113.12 | -$238.62 | -$40.38 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$24.05 | $1.56 | $1.36 | |
| Net borrowings | -$185.4 | $24.73 | $160.38 | -$98.33 |
| Total cash flows from financing | -$190.3 | -$10.1 | $159.06 | -$104.19 |
| Effect of exchange rate | $2.6 | -$2.69 | -$4.29 | $4.45 |
| Change in cash and equivalents | -$104.2 | $3.55 | $40.51 | $24.94 |
News
Fundamentals
| Market cap | $4.13B |
|---|---|
| Enterprise value | $4.05B |
| Shares outstanding | 18.60M |
| Revenue | $908.40M |
|---|---|
| EBITDA | $137.50M |
| EBIT | $86.40M |
| Net Income | $56.60M |
| Revenue Q/Q | -8.55% |
| Revenue Y/Y | -6.46% |
| P/E ratio | 73.02 |
|---|---|
| EV/Sales | 4.46 |
| EV/EBITDA | 29.46 |
| EV/EBIT | 46.88 |
| P/S ratio | 4.55 |
| P/B ratio | 3.12 |
| Book/Share | 71.26 |
| Cash/Share | 7.08 |
| EPS | $3.04 |
|---|---|
| ROA | 3.64% |
| ROE | 4.66% |
| Debt/Equity | 0.21 |
|---|---|
| Net debt/EBITDA | 0.92 |
| Current ratio | 4.53 |
| Quick ratio | 3.21 |